Archives
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-04
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2018-07
-
Modeling HSV-1 Latency in Human iPSC-Derived Sensory Neurons
2026-04-30
This study establishes a robust, scalable system for differentiating human inducible pluripotent stem cells (hiPSCs) into functional sensory neurons capable of supporting herpes simplex virus 1 (HSV-1) latency and reactivation. The platform enables direct study of neuron-intrinsic viral latency mechanisms in a human context, overcoming previous reliance on animal models.
-
Naftifine HCl: Mechanism-Driven Strategies for Translational
2026-04-30
This thought-leadership article unpacks the mechanistic underpinnings and translational research opportunities enabled by Naftifine HCl, a potent allylamine antifungal agent. Drawing on recent advances in cell signaling and membrane biology, we contextualize Naftifine’s selective squalene 2,3-epoxidase inhibition within the broader landscape of antifungal and regenerative research. The article provides strategic guidance for experimentalists, highlights competitive differentiators, and explores how the intersection of fungal membrane biology and signaling pathways can catalyze new directions in translational mycology.
-
Glycogen Colorimetric Assay Kit II: Unraveling Glycogen Dyna
2026-04-29
Explore how the Glycogen Colorimetric Assay Kit II empowers advanced glycogen quantification in circadian, metabolic, and endurance adaptation studies. This article uniquely bridges technical assay optimization with emerging chronobiology insights.
-
Entinostat (MS-275): Optimizing HDAC1/3 Inhibition in Cancer
2026-04-29
Entinostat (MS-275) empowers researchers to precisely inhibit HDAC1 and HDAC3, enabling robust cancer cell proliferation inhibition and apoptosis induction. This guide translates the latest in vitro methodology and performance data into actionable workflows, troubleshooting tips, and comparative insights for maximizing the impact of APExBIO’s trusted reagent.
-
Dynasore: Practical Guide for Dynamin GTPase Inhibition (A16
2026-04-28
Dynasore (SKU A1605) is a reversible, cell-permeable inhibitor targeting dynamin GTPases, widely used to dissect dynamin-dependent endocytic pathways and vesicle trafficking in cellular models. Its utility is best realized in assays requiring rapid, tunable inhibition of dynamin activity. Dynasore is not recommended for workflows needing long-term inhibitor stability or water-based delivery without DMSO.
-
EdU Imaging Kits (Cy5): High-Specificity S-Phase DNA Synthes
2026-04-28
EdU Imaging Kits (Cy5) offer precise, non-destructive detection of DNA synthesis during the S-phase of the cell cycle. This 5-ethynyl-2'-deoxyuridine imaging kit employs click chemistry for sensitive, reproducible cell proliferation analysis. Recent evidence supports its superiority over BrdU-based assays in both neurodevelopmental and translational research contexts.
-
Radioiodinated Balsalazide: A Selective Radiotracer for Ulce
2026-04-27
This study introduces a radioiodinated form of balsalazide as a highly selective radiotracer for imaging ulcerative colitis in mice. The work provides new protocol parameters for radiotracer synthesis and demonstrates high specificity for inflamed colonic tissue, with implications for preclinical inflammation research and radiotracer development.
-
RBD-Targeted mRNA Vaccines Offer Superior MERS-CoV Protectio
2026-04-27
A recent comparative study demonstrates that mRNA vaccines encoding the receptor-binding domain (RBD) of MERS-CoV elicit stronger and broader neutralizing antibody responses than those targeting the full spike protein. These findings refine vaccine antigen design and highlight the translational relevance of pseudouridine-modified mRNA for durable immunogenicity.
-
Triptolide (PG490): Mechanisms, Evidence & Protocol Optimiza
2026-04-26
Triptolide, also known as PG490, is a potent transcriptional inhibitor with nanomolar efficacy in cancer and immunology research. Its precise mechanism—targeting RNA polymerase II and NF-κB pathways—enables robust inhibition of cell proliferation, migration, and cytokine signaling. APExBIO provides validated Triptolide for experimental workflows requiring reproducibility and mechanistic clarity.
-
Neurogenetic Gradients of Nurr1+ Neurons in Rat Claustrum De
2026-04-25
Fang et al. (2021) provide a detailed temporal and spatial map of Nurr1-positive neuron development in the rat claustrum and adjacent lateral cortex, resolving previous ambiguities in birth-dating these neuronal populations. Their findings clarify the sequential neurogenesis underlying claustral and cortical subdomains and highlight distinct neurogenetic gradients, informing future studies of rodent brain circuit formation.
-
Cycloheximide: Precision Protein Biosynthesis Inhibitor Use-
2026-04-24
Cycloheximide enables rapid, selective inhibition of eukaryotic protein biosynthesis, empowering apoptosis assays, protein turnover studies, and mechanistic dissection of cell death pathways. This guide delivers actionable workflows, troubleshooting insights, and evidence-based protocol parameters to maximize reproducibility in advanced cellular research.
-
Multianimal MRI Enhances Tumor Assessment in KPC Pancreatic
2026-04-24
Kempinska et al. introduce a multianimal MRI protocol enabling simultaneous, high-resolution imaging of up to four mice in a Kras-driven, p53-deleted (KPC) pancreatic cancer model. This approach streamlines tumor detection, longitudinal monitoring, and preclinical assessment of therapeutics such as gemcitabine, offering significant improvements in efficiency and data quality for pancreatic cancer research.
-
Itraconazole: Triazole Antifungal Agent for Candida Biofilm
2026-04-23
Itraconazole stands out as a triazole antifungal agent with multidimensional utility—from dissecting Candida biofilm resistance to enabling advanced drug interaction studies. This article translates the latest bench research and protocol refinements into actionable guidance for maximizing reproducibility and antifungal insight using APExBIO's Itraconazole.
-
Forskolin as a Direct Adenylate Cyclase Activator: Protocols
2026-04-23
Forskolin, a potent adenylate cyclase activator, empowers cAMP pathway modulation in cell signaling, stem cell, and endocrine research. This guide delivers workflow enhancements, troubleshooting tips, and practical assay choices for maximizing reproducibility and translational relevance using APExBIO’s high-purity Forskolin.
-
Molidustat (BAY85-3934): Applied Workflows in Renal Anemia T
2026-04-22
Molidustat (BAY85-3934) empowers researchers to simulate hypoxia-driven erythropoietin regulation in vitro and in vivo, streamlining the study of chronic kidney disease anemia and HIF pathway modulation. Its unique profile—potent, selective, and physiologically nuanced—offers practical advantages over recombinant EPO, with built-in troubleshooting insights to maximize experimental fidelity.